日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano study

一种用于淋巴瘤预后分类的新型真实世界数据方法：卢加诺真实世界研究

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2025-0134
Swain, Richard Scott; Klink, Andrew; Asgarisabet, Parisa; Zimmerman Savill, Kristin M; Kalesan, Bindu; Balanean, Alexandrina; Hays, Harlen; Kaufman, Jill; McAllister, Lindsay; Omary, Courtney; Yu, Hsing-Ting; Laney, JaLyna; Richardson, Nicholas C; Lerro, Catherine C; Rizvi, Fatima; Vallejo, Jonathon; Wang, Kun; Theoret, Marc R; Rivera, Donna R; Feinberg, Bruce A
淋巴瘤
发表日期：2026
文献求助 收藏

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

美国食品药品监督管理局批准摘要：伊美替司他用于治疗部分低危至中危-1型骨髓增生异常综合征伴输血依赖性贫血患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01369
Kim, Nina; Pulte, E Dianne; Ehrlich, Lori A; Ionan, Alexei C; Haupert, Spencer; Vallejo, Jonathon; Green, Francis; Zheng, Nan; Wang, Yun; Liu, Jiang; Blanco, Javier G; Dorff, Sarah E; Booth, Brian; Choe, Moran; Gehrke, Brenda; Bhatnagar, Vishal; Theoret, Marc; Pazdur, Richard; De Claro, R Angelo; Norsworthy, Kelly J
贫血
代谢
发表日期：2025
文献求助 收藏

Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology

综合所有证据：优化肿瘤剂量选择策略

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00488
Levit, Laura A; Shah, Mirat; Ratain, Mark J; Garrett-Mayer, Elizabeth; Rahman, Atiqur; Theoret, Marc; Harvey, R Donald
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

FDA批准摘要：奥鲁西地尼用于治疗伴有异柠檬酸脱氢酶1突变的复发或难治性急性髓系白血病成人患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2196
Woods, Ashley C; Norsworthy, Kelly J; Choe, Moran; Gehrke, Brenda J; Chen, Haiyan; Vallejo, Jonathon; Pan, Lili; Jiang, Xiling; Li, Hongshan; Kraft, Jeffrey; Liu, Jiang; Charlab, Rosane; Okusanya, Olanrewaju O; Booth, Brian; Pazdur, Richard; Theoret, Marc R; Angelo de Claro, R
白血病
发表日期：2025
文献求助 收藏

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

FDA批准摘要：Blinatumomab用于多阶段化疗巩固期治疗B细胞前体急性淋巴细胞白血病

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1034
Rabik, Cara A; Wang, Shu; Chadda, Ritu; Przepiorka, Donna; Vallejo, Jonathon; Jiang, Xiling; Theoret, Marc R; de Claro, R Angelo
白血病
细胞生物学
B细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

FDA Approval Summary: Lisocabtagene Maraleucel for Relapsed or Refractory Follicular Lymphoma

FDA批准摘要：Lisocabtagene Maraleucel用于治疗复发或难治性滤泡性淋巴瘤

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1035
Britton, Kristen; Mahat, Upendra; Richardson, Nicholas C; Tegenge, Million; Gao, Qianmiao; Theoret, Marc R; Fashoyin-Aje, Lola A
淋巴瘤
发表日期：2025
文献求助 收藏

Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better

儿童肿瘤药物剂量优化：我们的患者值得更好的治疗

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4325
Wessel, Kristin M; Drezner, Nicole; Shord, Stacy S; Shah, Mirat; Theoret, Marc R; Donoghue, Martha
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class-Exposed, Relapsed or Refractory Multiple Myeloma

FDA批准摘要：Idecabtagene Vicleucel用于治疗三类药物暴露、复发或难治性多发性骨髓瘤

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4181
Sharma, Poornima; Lin, Xue; Xu, Zhenzhen; Kanapuru, Bindu; Theoret, Marc R; Sokolic, Robert; Fashoyin-Aje, Lola A
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy

FDA批准摘要：阿沙利单抗适用于体重至少40公斤且既往接受过两线全身治疗后出现慢性移植物抗宿主病（GVHD）的成人和儿童患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0896
Le, Robert Q; Godder, Kamar; Wang, Jingyan; Collazo, Justin S; Konicki, Robyn; Choe, Moran; Feng, Monica; Przepiorka, Donna; Vallejo, Jonathon; Shah, Ankit; Liu, Jiang; Gehrke, Brenda J; Wilson, Willie; Siegel, Andrea; Wu, Yun; Kuo, Charles Yuan-Chia; Ray, Melissa; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo
发表日期：2025
文献求助 收藏

FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation

FDA批准摘要：Ivosidenib用于治疗伴有IDH1突变的复发/难治性骨髓增生异常综合征成人患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1005
Woods, Ashley C; Pulte, E Dianne; Wang, Xin; Vallejo, Jonathon; Chadda, Ritu; Zheng, Nan; Blanco, Javier G; Dorff, Sarah E; Li, Hongshan; Liu, Jiang; Okusanya, Olanrewaju O; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo; Norsworthy, Kelly J
发表日期：2025
文献求助 收藏